Thought Leaders in

Precision Medicine

The COVID-19 pandemic revealed that PCR Technology is the emerging gold standard for swab testing patients’ specimens for pathogen detection and diagnosis. Our CLIA certified laboratory has been a pioneer in the testing field since our inception in 2017, long before the devastating pandemic was announced. NCF Diagnostics & DNA Technologies invests in training and education to develop laboratory infrastructure and maintain a highly skilled team of experts. Innovating new pathogen tests daily, NCF Diagnostics & DNA Technologies endeavors to continue leading PCR Testing with our exceptional workforce, always keeping the “patient first” philosophy of care.

Thought Leaders in Precision Medicine

The COVID-19 pandemic revealed that PCR Technology is the emerging gold standard for swab testing patients’ specimens for pathogen detection and diagnosis. Our CLIA certified laboratory has been a pioneer in the testing field since our inception in 2017, long before the devastating pandemic was announced. NCF Diagnostics & DNA Technologies invests in training and education to develop laboratory infrastructure and maintain a highly skilled team of experts. Innovating new pathogen tests daily, NCF Diagnostics & DNA Technologies endeavors to continue leading PCR Testing with our exceptional workforce, always keeping the “patient first” philosophy of care.

Accurate

Real-Time PCR testing provides precision test results for highly targeted treatments.

Fast

Test results are delivered within 24 hours.

Revolutionary

Emerging DNA Technology empowers the physician and patient, revolutionizing health care.

Empowering Providers Through Molecular Technologies

Empowering Providers Through Molecular Technologies

Every Year in the United States….

20 million

COVID-19 patients tested in 2020.

38 million

Respiratory Illnesses in 2019-2020.

105 million

Gastroinestinal Disorders yearly.

2 million

Serious adverse reactions linked to antibiotics annually.

COVID-19 Death Toll: 530,000

and rising daily. The COVID-19 pandemic rages on, devastating patients, families and populations worldwide.

22,000

Deaths annually due to Flu viruses alone.

C. DIFF

Hospitalizes 250,000 patients annually, and 236,000 deaths result each year from Norovirus, C. diff and other common pathogens.

23,000

Deaths annually from antibiotic resistant infections.

Every Year in the United States….

20 million

COVID-19 patients tested in 2020.

COVID-19 Death Toll: 530,000

and rising daily. The COVID-19 pandemic rages on, devastating patients, families and populations worldwide.

38 million

Respiratory Illnesses in 2019-2020.

22,000

Deaths annually due to Flu viruses alone.

105 million

Gastroinestinal Disorders yearly.

C. DIFF

Hospitalizes 250,000 patients annually, and 236,000 deaths result each year from Norovirus, C. diff and other common pathogens.

2 million

Serious adverse reactions linked to antibiotics annually.

23,000

Deaths annually from antibiotic resistant infections.